Millennium Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Millennium Management's MDGL Position: Q3 2026 in Review
Millennium Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 90% in Q3 2026, selling an estimated $38.5M and leaving 8,295 shares worth $4.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3237.
Millennium Management first reported a position in MDGL in Q2 2013 and has held it in 41 quarters since. The position peaked at $43.6M in Q2 2026. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Millennium Management held 8,295 shares of Madrigal Pharmaceuticals worth $4.18M as of Q3 2026.
- Millennium Management sold 72,901 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $38.5M.
- Madrigal Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3237 holding.
- Millennium Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
- Millennium Management's Madrigal Pharmaceuticals position peaked at $43.6M in Q2 2026.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.